Cipla Closes Two Marketing Divisions, Shifting Work To Two Remaining
This article was originally published in PharmAsia News
Executive Summary
Cipla said it has shuttered two of its generic-drug marketing divisions, Protec and Omnicare, in a move to improve its distribution network